NEW YORK STATE COMMON RETIREMENT FUND - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,328
-44.1%
402,944
+33.9%
0.02%
-37.1%
Q2 2023$27,421
+71.0%
300,995
+23.8%
0.04%
+66.7%
Q1 2023$16,036
+197.0%
243,120
+132.8%
0.02%
+200.0%
Q4 2022$5,400
-99.9%
104,420
-30.4%
0.01%
-53.3%
Q3 2022$10,242,000
+148.1%
149,954
+64.2%
0.02%
+200.0%
Q2 2022$4,129,000
+4.6%
91,306
+17.5%
0.01%
+25.0%
Q1 2022$3,947,000
+26.8%
77,691
+18.0%
0.00%
+33.3%
Q4 2021$3,112,000
+100.9%
65,814
+40.0%
0.00%
+50.0%
Q3 2021$1,549,000
-63.8%
47,004
-30.6%
0.00%
-50.0%
Q2 2021$4,283,000
+81.5%
67,765
+23.2%
0.00%
+33.3%
Q1 2021$2,360,000
-34.2%
55,000
-12.3%
0.00%
-25.0%
Q4 2020$3,586,000
+116.2%
62,685
+14.0%
0.00%
+100.0%
Q3 2020$1,659,000
-7.6%
55,0000.0%0.00%0.0%
Q2 2020$1,796,000
+32.3%
55,000
+8.5%
0.00%0.0%
Q1 2020$1,358,000
+2.2%
50,700
+16.8%
0.00%0.0%
Q4 2019$1,329,000
+10.6%
43,400
-13.0%
0.00%0.0%
Q3 2019$1,202,000
-4.1%
49,900
+0.8%
0.00%0.0%
Q2 2019$1,254,000
+88.6%
49,500
+45.2%
0.00%
+100.0%
Q1 2019$665,000
+47.8%
34,1000.0%0.00%0.0%
Q4 2018$450,000
-37.1%
34,100
-15.2%
0.00%0.0%
Q3 2018$715,000
-19.1%
40,2000.0%0.00%0.0%
Q2 2018$884,000
+260.8%
40,200
+262.2%
0.00%
Q1 2018$245,00011,1000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,160,000$163,403,60025.44%
Avoro Capital Advisors LLC 10,625,000$549,418,7508.21%
Logos Global Management LP 1,350,000$69,808,5008.18%
EcoR1 Capital, LLC 5,183,431$268,035,2178.16%
Saturn V Capital Management LP 212,329$9,414,3197.81%
ACUTA CAPITAL PARTNERS, LLC 217,500$11,246,9256.92%
Ghost Tree Capital, LLC 300,000$15,513,0006.62%
Finepoint Capital LP 334,890$17,3175.60%
Cormorant Asset Management, LP 1,576,872$81,5405.46%
Tri Locum Partners LP 221,897$11,474,0004.64%
View complete list of APELLIS PHARMACEUTICALS INC shareholders